Onconetix Inc
NASDAQ:ONCO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Onconetix Inc
NASDAQ:ONCO
|
US |
|
M
|
Metallica Metals Corp
CNSX:MM
|
CA |
|
FiEE Inc
NASDAQ:FIEE
|
US |
|
XTC Lithium Ltd
OTC:XTCPF
|
AU |
|
A
|
AE Fuels Corp
OTC:NRGFF
|
CA |
|
S
|
Sino United Worldwide Consolidated Ltd
OTC:SUIC
|
US |
|
Aspire Biopharma Holdings Inc
NASDAQ:ASBP
|
PR |
|
Crypto Co
OTC:CRCW
|
US |
|
Lombard Medical Inc
OTC:EVARF
|
UK |
|
S
|
Sanofi SA
XBER:SNW
|
FR |
|
Anabuki Kosan Inc
TSE:8928
|
JP |
|
Y
|
York Space Systems Inc
NYSE:YSS
|
US |
|
C
|
China Fishery Group Ltd
SGX:B0Z
|
HK |
|
D
|
DigiMax Global Inc
OTC:DBKSF
|
CA |
Cash Flow Statement
Cash Flow Statement
Onconetix Inc
| Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(2)
|
(3)
|
(3)
|
(5)
|
(9)
|
(11)
|
(13)
|
(14)
|
(17)
|
(18)
|
(37)
|
(46)
|
(53)
|
(52)
|
(59)
|
(56)
|
(44)
|
(49)
|
(14)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
|
| Change in Deffered Taxes |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
0
|
0
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
5
|
5
|
22
|
30
|
38
|
39
|
50
|
49
|
38
|
43
|
7
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Change in Working Capital |
1
|
1
|
1
|
2
|
2
|
3
|
3
|
(0)
|
1
|
1
|
2
|
2
|
(1)
|
(1)
|
(2)
|
0
|
2
|
(1)
|
(2)
|
|
| Cash from Operating Activities |
(1)
N/A
|
(2)
-46%
|
(2)
-24%
|
(3)
-44%
|
(5)
-87%
|
(7)
-20%
|
(9)
-32%
|
(12)
-41%
|
(11)
+11%
|
(12)
-11%
|
(14)
-13%
|
(14)
-6%
|
(16)
-10%
|
(14)
+12%
|
(10)
+24%
|
(7)
+31%
|
(5)
+25%
|
(8)
-37%
|
(10)
-29%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(6)
|
(6)
|
(6)
|
(6)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(3)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
0
N/A
|
0
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
(0)
N/A
|
0
N/A
|
(10)
N/A
|
(10)
+2%
|
(9)
+12%
|
(9)
0%
|
1
N/A
|
1
-13%
|
(0)
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
18
|
26
|
35
|
34
|
16
|
9
|
2
|
2
|
2
|
2
|
1
|
3
|
7
|
8
|
17
|
20
|
|
| Net Issuance of Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
5
|
4
|
5
|
4
|
(3)
|
(3)
|
(7)
|
(6)
|
|
| Other |
0
|
(0)
|
(0)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
(0)
N/A
|
(0)
-65%
|
17
N/A
|
24
+40%
|
33
+37%
|
33
-1%
|
15
-54%
|
8
-47%
|
0
-94%
|
1
+130%
|
6
+508%
|
6
-2%
|
5
-12%
|
7
+24%
|
4
-35%
|
5
+25%
|
9
+68%
|
14
+57%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
|
| Net Change in Cash |
(1)
N/A
|
(2)
-64%
|
(2)
-29%
|
14
N/A
|
19
+30%
|
26
+42%
|
24
-10%
|
3
-89%
|
(13)
N/A
|
(21)
-65%
|
(21)
+1%
|
(17)
+21%
|
(8)
+51%
|
(7)
+12%
|
(4)
+47%
|
(3)
+26%
|
(1)
+78%
|
0
N/A
|
5
+824%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(1)
N/A
|
(2)
-46%
|
(2)
-24%
|
(3)
-44%
|
(5)
-86%
|
(7)
-20%
|
(9)
-32%
|
(12)
-41%
|
(17)
-38%
|
(18)
-7%
|
(20)
-8%
|
(21)
-4%
|
(16)
+23%
|
(14)
+12%
|
(11)
+24%
|
(7)
+31%
|
(5)
+25%
|
(8)
-37%
|
(10)
-29%
|
|